LUPKYNIS

Aurinia Pharmaceuticals Inc.

Application Filed: 2019-10-29
Trademark Application Details
Trademark Logo LUPKYNIS

Mark For: LUPKYNIS® trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal segmental glomerulosclerosis. [all]

Status

2021-02-10 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88672395
Registration Number6397451
Mark Literal ElementsLUPKYNIS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-05-05
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Domestic RepresentativeMatthew R. Wilmot
Attorney NameMatthew R. Wilmot
Attorney Docket Number66570-11

Timeline

2019-10-29Application Filed
2019-11-01Location: NEW APPLICATION PROCESSING
2019-11-01Status: Live/Pending
2019-11-02Transaction Date
2020-03-10Published
2020-05-05Location: INTENT TO USE SECTION
2020-10-08Status: A first request for extension of time to file a Statement of Use has been granted.
2021-06-22Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Aurinia Pharmaceuticals Inc.
Address1203-4464 Markham Street Victoria, BC CANADA V8Z7X8
Legal Entity TypeCompany
Legal Entity StateCANADA

Attorney of Record

MATTHEW R. WILMOT
STOEL RIVES LLP
760 SW NINTH AVENUE, SUITE 3000
PORTLAND, OR 97205

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal segmental glomerulosclerosis

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal segmental glomerulosclerosis
GS0051Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal segmental glomerulosclerosis

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-10-10
TEAS EXTENSION RECEIVED2020-10-08
EXTENSION 1 GRANTED2020-10-0898765
EXTENSION 1 FILED2020-10-0898765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-05-05
PUBLISHED FOR OPPOSITION2020-03-10
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-03-10
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-02-19
APPROVED FOR PUB - PRINCIPAL REGISTER2020-02-05
ASSIGNED TO EXAMINER2020-02-0394484
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-11-01
NEW APPLICATION ENTERED IN TRAM2019-11-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed